Company Search:
Advanced Search
Sponsored Links
Eurocine Vaccines AB Company Snapshot
Eurocine Vaccines AB operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Eurocine Vaccines AB with three other companies in this sector in Sweden: Biovica International AB (2015 sales of 458,674.00 Swedish Kronor [US$56,990.24 ] ), Xbrane Biopharma Ab (392,859.00 Swedish Kronor [US$48,812.73 ] ), and Xintela AB (757,000.00 Swedish Kronor [US$94,057.25 ] ).

Sales Analysis.
  Stock Performance Chart for Eurocine Vaccines AB
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 1.89
(Figures in Swedish Kronor)
1 Week 3.4%   13 Weeks -9.1%  
4 Weeks -32.1%   52 Weeks -41.2%  
Eurocine Vaccines AB Key Data:
  Ticker: EUCI Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 550,000
(Year Ending Jan 2016).
Employees: 3
  Currency: Swedish Kronor Market Cap: 135,424,245
  Fiscal Yr Ends: June Shares Outstanding: 71,653,040
  Share Type: Aktie Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.